Zobrazeno 1 - 10
of 17
pro vyhledávání: '"J Goncalves Almeida"'
Publikováno v:
European Heart Journal. 43
Introduction The EXPLORER-HCM trial evaluated the safety and efficacy of Mavacamten, a cardiac myosin inhibitor, in symptomatic obstructive hypertrophic cardiomyopathy (HCM). Mavacamten improved symptoms, exercise capacity and left ventricular outflo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b58d4dd87425857031894cf20d57beef
https://doi.org/10.1093/eurheartj/ehac544.1731
https://doi.org/10.1093/eurheartj/ehac544.1731
Autor:
M Brandao, J Goncalves Almeida, P Fonseca, E Santos, F Rosas, A J Tavares, J Nogueira Ribeiro, M Oliveira, H Goncalves, J Primo, R Fontes-Carvalho
Publikováno v:
European Heart Journal. 43
Background Resynchronization therapy (CRT) reduces mortality across all etiologies of heart failure (HF). Reverse left ventricular (LV) remodelling has been reported to occur more often in non-ischemic patients. Purpose To compare response and outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e57b0e87c0512ab77cf19b2dc1eeb9fe
https://doi.org/10.1093/eurheartj/ehac544.1000
https://doi.org/10.1093/eurheartj/ehac544.1000
Publikováno v:
European Heart Journal. 43
Introduction Progression of hypertrophic cardiomyopathy (HCM) with incident left ventricular (LV) dysfunction (HCM-LVSD) is associated with poor prognosis and advanced heart failure (HF). Prevalence ranges from 5–10% in previous studies. Identifica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0006a7e002a6c206f6d6287d80645a5a
https://doi.org/10.1093/eurheartj/ehac544.1730
https://doi.org/10.1093/eurheartj/ehac544.1730
Autor:
M Brandao, G Santos Silva, M Ribeiro Silva, P Ribeiro Queiros, P Goncalves Teixeira, J Goncalves Almeida, G Pires-Morais, M Oliveira, A Rodrigues, P Braga, D Caeiro, R Fontes-Carvalho
Publikováno v:
European Heart Journal. Acute Cardiovascular Care. 11
Funding Acknowledgements Type of funding sources: None. Background The Impella is a percutaneous ventricular assist device that unloads the left ventricle by ejecting blood to the aorta. Its use in cases of cardiogenic shock (CS) and high-risk percut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49802e82bd4e698f9a07df263f4166f2
https://doi.org/10.1093/ehjacc/zuac041.061
https://doi.org/10.1093/ehjacc/zuac041.061
Autor:
Ricardo Fontes-Carvalho, João Primo, M Brandao, Filipe Rosas, J Ribeiro, M Oliveira, P. E. Fonseca, J Goncalves Almeida, Hernâni Gonçalves, Elerson R. S. Santos
Publikováno v:
European Heart Journal. 42
Background Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in selected patients (pts) with heart failure (HF). Pts with atrial fibrillation (AF) were excluded from major CRT trials. Studies suggested that pts with AF derive le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfa56ecce6bffc1a20e15b8ef0d1a527
https://doi.org/10.1093/eurheartj/ehab724.0704
https://doi.org/10.1093/eurheartj/ehab724.0704
Autor:
Hernâni Gonçalves, M Oliveira, Elerson R. S. Santos, Ricardo Fontes-Carvalho, João Primo, P. E. Fonseca, J Ribeiro, Filipe Rosas, M Brandao, J Goncalves Almeida
Publikováno v:
EP Europace. 23
Funding Acknowledgements Type of funding sources: None. BACKGROUND Resynchronization therapy (CRT) reduces morbidity and mortality in selected patients with heart failure with reduced ejection fraction (HFrEF). Patients that experience significant re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1983b4ba55e96090c743498373c8fba
https://doi.org/10.1093/europace/euab116.447
https://doi.org/10.1093/europace/euab116.447
Autor:
M Brandao, Elerson R. S. Santos, J Goncalves Almeida, Filipe Rosas, João Primo, Hernâni Gonçalves, Ricardo Fontes-Carvalho, M Oliveira, J Ribeiro, P. E. Fonseca
Publikováno v:
EP Europace. 23
Funding Acknowledgements Type of funding sources: None. BACKGROUND Upgrade to resynchronization therapy (CRT) is common practice in Europe. However, guideline recommendations are discordant and randomized trials are lacking. Previous studies have sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a7741621eda70232f64bbc66c5934c5
https://doi.org/10.1093/europace/euab116.448
https://doi.org/10.1093/europace/euab116.448
Autor:
P. E. Fonseca, Filipe Rosas, Elerson R. S. Santos, Ricardo Fontes-Carvalho, Hernâni Gonçalves, J Goncalves Almeida, J Ribeiro, M Brandao, M Oliveira, João Primo
Publikováno v:
EP Europace. 23
Funding Acknowledgements Type of funding sources: None. BACKGROUND Upgrade to resynchronization therapy (CRT) is common practice in Europe. However, patient selection remains a challenge. Data regarding predictors of response to upgrade is currently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36e6833739b658d78e302f396d9a86d5
https://doi.org/10.1093/europace/euab116.446
https://doi.org/10.1093/europace/euab116.446
Autor:
J.P Monteiro, M Brandao, Elerson R. S. Santos, Filipe Rosas, P. E. Fonseca, F Montenegro Sa, J Goncalves Almeida, Hernâni Gonçalves, João Primo, M Oliveira, Patrícia Aparecida de Campos Braga, J Ribeiro
Publikováno v:
Web of Science
Background Upgrade to resynchronization therapy (CRT) from conventional pacemaker (P) or defibrillator (D) is common practice in Europe. However, guidelines (GL) are discordant: Pacing GL give a class I recommendation, while Heart Failure (HF) GL pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::549bc85b919e648d8d59c35464efbe56
https://doi.org/10.1093/ehjci/ehaa946.0795
https://doi.org/10.1093/ehjci/ehaa946.0795
Autor:
Ana Raquel Barbosa, Vasco Gama, M Fonseca, Paula Teixeira, Catarina Ruivo, C Espada Guerreiro, Hernâni Gonçalves, J Goncalves Almeida, N Dias Ferreira
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::544aa03fe80075e3b976720559afb762
https://doi.org/10.1093/eurheartj/ehy563.p4521
https://doi.org/10.1093/eurheartj/ehy563.p4521